- Home
- SWKH vs FLC Comparison
SWKH vs FLC Comparison
Compare SWKH & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SWKH | FLC |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.9M | 184.0M |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | SWKH | FLC |
|---|---|---|
| Price | $16.41 | $17.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 18.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $52.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.00 | $14.80 |
| 52 Week High | $18.66 | $18.09 |
Technical Indicators
Market Signals| Indicator | SWKH | FLC |
|---|---|---|
| Relative Strength Index (RSI) | 26.80 | 45.16 |
| Support Level | $16.15 | $17.45 |
| Resistance Level | $17.71 | $17.72 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 12.90 | 0.00 |
Price Performance
Historical ComparisonAbout SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.